These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 28913092)

  • 21. The association between endometrial thickness and pregnancy outcome in gonadotropin-stimulated intrauterine insemination cycles.
    Liu Y; Ye XY; Chan C
    Reprod Biol Endocrinol; 2019 Jan; 17(1):14. PubMed ID: 30674305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of luteal phase support on pregnancy rates in intrauterine insemination cycles: a prospective randomized study.
    Erdem A; Erdem M; Atmaca S; Guler I
    Fertil Steril; 2009 Jun; 91(6):2508-13. PubMed ID: 18692788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of pregnancy rates in pre-treatment male infertility and low total motile sperm count at insemination.
    Xiao CW; Agbo C; Dahan MH
    Arch Gynecol Obstet; 2016 Jan; 293(1):211-217. PubMed ID: 26288981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of Letrozole-HMG and Clomiphene-HMG on Incidence of Luteinized Unruptured Follicle Syndrome in Infertile Women Undergoing Induction Ovulation and Intrauterine Insemination: A Randomised Trial.
    Azmoodeh A; Pejman Manesh M; Akbari Asbagh F; Ghaseminejad A; Hamzehgardeshi Z
    Glob J Health Sci; 2015 Sep; 8(4):244-52. PubMed ID: 26573024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized comparison of ovulation induction and hormone profile between the aromatase inhibitor anastrozole and clomiphene citrate in women with infertility.
    Wu HH; Wang NM; Cheng ML; Hsieh JN
    Gynecol Endocrinol; 2007 Feb; 23(2):76-81. PubMed ID: 17454156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated serum progesterone-to-estradiol ratio during gonadotropin stimulation for intrauterine insemination or in vitro fertilization is not associated with diminished ovarian reserve.
    Hofmann GE; Khoury J; Michener C
    Fertil Steril; 2002 Jul; 78(1):47-50. PubMed ID: 12095489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Minimum values for midluteal plasma progesterone and estradiol concentrations in patients who achieved pregnancy with timed intercourse or intrauterine insemination without a human menopausal gonadotropin.
    Takaya Y; Matsubayashi H; Kitaya K; Nishiyama R; Yamaguchi K; Takeuchi T; Ishikawa T
    BMC Res Notes; 2018 Jan; 11(1):61. PubMed ID: 29357944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Luteal phase support after mild ovulation induction with intrauterine insemination: an on-going debate.
    Aytac PC; Bulgan Kilicdag E; Haydardedeoglu B; Simsek E; Cok T; Coban G
    Gynecol Endocrinol; 2016 Jul; 32(7):543-7. PubMed ID: 26850073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of luteal phase support after ovulation induction and intrauterine insemination.
    Oktem M; Altinkaya SO; Yilmaz SA; Bozkurt N; Erdem M; Erdem A; Gumuslu S
    Gynecol Endocrinol; 2014; 30(12):909-12. PubMed ID: 25102275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intrauterine insemination: simultaneous with or 36 h after HCG? A randomized clinical trial.
    Rijsdijk OE; Cantineau AE; Bourdrez P; Gijsen TP; Gondrie ET; Sprengers O; Vrouenraets FP; Donners JJ; Evers JL; Smits LJ; den Hartog JE
    Reprod Biomed Online; 2019 Aug; 39(2):262-268. PubMed ID: 31182355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cycle-specific and cumulative fecundity in patients with endometriosis who are undergoing controlled ovarian hyperstimulation-intrauterine insemination or in vitro fertilization-embryo transfer.
    Dmowski WP; Pry M; Ding J; Rana N
    Fertil Steril; 2002 Oct; 78(4):750-6. PubMed ID: 12372451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gonadotropin-releasing hormone antagonist use is associated with increased pregnancy rates in ovulation induction-intrauterine insemination to in vitro fertilization conversions, independent of age and estradiol level on the day of human chorionic gonadotropin administration.
    Quaas AM; Missmer SA; Ginsburg ES
    Fertil Steril; 2010 Feb; 93(2):605-8. PubMed ID: 19324340
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-dose human menopausal gonadotrophin versus clomiphene citrate in subfertile couples treated with intrauterine insemination: a randomized controlled trial.
    Peeraer K; Debrock S; De Loecker P; Tomassetti C; Laenen A; Welkenhuysen M; Meeuwis L; Pelckmans S; Mol BW; Spiessens C; De Neubourg D; D'Hooghe TM
    Hum Reprod; 2015 May; 30(5):1079-88. PubMed ID: 25788569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Should an intrauterine insemination with donor semen be performed 1 or 2 days after the spontaneous LH rise? A prospective RCT.
    Blockeel C; Knez J; Polyzos NP; De Vos M; Camus M; Tournaye H
    Hum Reprod; 2014 Apr; 29(4):697-703. PubMed ID: 24549212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Double vs. single intrauterine insemination per cycle: use in gonadotropin cycles and in diagnostic categories of ovulatory dysfunction and male factor infertility.
    Randall GW; Gantt PA
    J Reprod Med; 2008 Mar; 53(3):196-202. PubMed ID: 18441725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endocrine modifications associated with final oocyte maturation with gonadotropin-releasing hormone agonists vs. human chorionic gonadotropin in women undergoing intrauterine insemination.
    Díaz I; Guillén A; Pacheco A; Requena A; Garcia-Velasco JA
    J Reprod Med; 2008 Jan; 53(1):33-9. PubMed ID: 18251359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Timing of intrauterine insemination: an attempt to unravel the enigma.
    Rahman SM; Karmakar D; Malhotra N; Kumar S
    Arch Gynecol Obstet; 2011 Oct; 284(4):1023-7. PubMed ID: 21710180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intrauterine insemination with ovarian stimulation versus expectant management for unexplained infertility (TUI): a pragmatic, open-label, randomised, controlled, two-centre trial.
    Farquhar CM; Liu E; Armstrong S; Arroll N; Lensen S; Brown J
    Lancet; 2018 Feb; 391(10119):441-450. PubMed ID: 29174128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictive value of mid luteal progesterone concentration before luteal support in controlled ovarian hyperstimulation with intrauterine insemination.
    Costello MF; Emerson S; Lukic J; Sjoblom P; Garrett D; Hughes G; Steigrad S
    Aust N Z J Obstet Gynaecol; 2004 Feb; 44(1):51-6. PubMed ID: 15089869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimal treatment for poor responders to ovarian stimulation: does in vitro insemination offer any advantages to intrauterine insemination?
    Wood S; Rahim R; Searle T; Sajjad Y; Troup S; Lewis-Jones I; Kingsland C
    Hum Fertil (Camb); 2003 Feb; 6(1):13-8. PubMed ID: 12663956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.